Pfizer Inc. (PFE)
27.98
-0.09
(-0.32%)
USD |
NYSE |
Aug 24, 16:00
27.96
-0.02
(-0.07%)
After-Hours: 20:00
Pfizer Enterprise Value : 211.77B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 211.77B |
| August 20, 2026 | 210.17B |
| August 19, 2026 | 212.74B |
| August 18, 2026 | 207.09B |
| August 17, 2026 | 204.93B |
| August 14, 2026 | 204.47B |
| August 13, 2026 | 204.53B |
| August 12, 2026 | 201.74B |
| August 11, 2026 | 203.50B |
| August 10, 2026 | 205.95B |
| August 07, 2026 | 204.30B |
| August 06, 2026 | 201.11B |
| August 05, 2026 | 198.89B |
| August 04, 2026 | 196.61B |
| August 03, 2026 | 194.44B |
| July 31, 2026 | 194.33B |
| July 30, 2026 | 193.76B |
| July 29, 2026 | 195.13B |
| July 28, 2026 | 195.70B |
| July 27, 2026 | 192.39B |
| July 24, 2026 | 191.65B |
| July 23, 2026 | 194.33B |
| July 22, 2026 | 193.25B |
| July 21, 2026 | 193.93B |
| July 20, 2026 | 192.85B |
| Date | Value |
|---|---|
| July 17, 2026 | 194.56B |
| July 16, 2026 | 195.07B |
| July 15, 2026 | 193.25B |
| July 14, 2026 | 190.00B |
| July 13, 2026 | 191.31B |
| July 10, 2026 | 189.54B |
| July 09, 2026 | 190.00B |
| July 08, 2026 | 188.86B |
| July 07, 2026 | 188.97B |
| July 06, 2026 | 186.98B |
| July 02, 2026 | 190.40B |
| July 01, 2026 | 187.89B |
| June 30, 2026 | 189.03B |
| June 29, 2026 | 190.57B |
| June 26, 2026 | 190.11B |
| June 25, 2026 | 186.58B |
| June 24, 2026 | 188.69B |
| June 23, 2026 | 192.56B |
| June 22, 2026 | 194.61B |
| June 18, 2026 | 195.35B |
| June 17, 2026 | 199.40B |
| June 16, 2026 | 200.08B |
| June 15, 2026 | 199.86B |
| June 12, 2026 | 201.05B |
| June 11, 2026 | 200.83B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Johnson & Johnson | 679.08B |
| Eli Lilly & Co. | 1.228T |
| Merck & Co., Inc. | 423.37B |
| Bristol Myers Squibb Co. | 170.89B |
| Viatris, Inc. | 31.07B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -246.00M |
| Revenue (Quarterly) | 15.03B |
| Total Expenses (Quarterly) | 15.29B |
| EPS Diluted (Quarterly) | -0.0435 |
| Gross Profit Margin (Quarterly) | 62.94% |
| Profit Margin (Quarterly) | -1.64% |
| Earnings Yield | 2.70% |
| Operating Earnings Yield | 10.60% |
| Normalized Earnings Yield | 8.659 |